Last reviewed · How we verify

NCT04910412

Effects of tDCS With Gait Training on Leg Performance in Incomplete Spinal Cord Injury

Completed NA Last updated 22 June 2022
What this trial tests

NA trial testing transcranial direct current stimulation in Incomplete Spinal Cord Injury in 34 participants. Completed in 31 May 2022.

Timeline
25 May 2021
Primary endpoint
30 April 2022
31 May 2022

Quick facts

Lead sponsorMahidol University
PhaseNA
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designfactorial
Maskingtriple
Primary purposetreatment
Enrollment34
Start date25 May 2021
Primary completion30 April 2022
Estimated completion31 May 2022
Sites1 location across Thailand

Drugs / interventions tested

Conditions studied

Sponsor

Mahidol University

Who can join

Adults 18 to 70, any sex, with Incomplete Spinal Cord Injury. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study aim to investigate the effects of anodal transcranial direct current stimulation combined with gait training for 5 consecutive session on gait performance, balance, sit to stand performance and quality of life in persons with incomplete SCI at post intervention, 1-month follow-up and 2-month follow up

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Combining Therapeutic Strategies to Treat the Injured Spinal Cord: A Translational Perspective.
    Sherman BC, Schmidt Read M, Hoh DJ, Guest JD, et al · · 2025 · cited 2× · PMID 40929022 · DOI 10.1177/08977151251371710

Verify or expand the search:

Other trials of transcranial direct current stimulation

Trials testing the same drug.

Other recruiting trials for Incomplete Spinal Cord Injury

Currently open trials in the same condition.

Other Mahidol University trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04910412.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing